IsoRay Inc (ISR)
0.3789
+0.01 +3.05%
NYSE AM
Mar 22, 20:00
Real time
USD
View All Key Stats
ISR Key Stats
| Income Statement | |
| Revenue (TTM) | 6.642M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.1069 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -6.612M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 40.18% |
| Profit Margin (Quarterly) | -74.26% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 25.51M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 3.480 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 2.640 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -1.225M |
| Return on Equity (TTM) | Upgrade |
View All ISR News
ISR News
-
WireHeadlineTime (ET)
-
Yahoo02/12 18:20
-
Yahoo02/12 17:19
-
SA Breaking News02/12 16:07
-
Globe Newswire02/12 16:05
-
Yahoo02/12 14:30
-
Yahoo02/05 10:30
-
Globe Newswire01/30 08:13
-
Yahoo01/29 08:13
-
Globe Newswire01/29 08:13
-
SA Breaking News12/17 13:17
View All Events
ISR Events
| Date | Type | Description |
|---|---|---|
| 09/25/2019 16:30 EDT | Misc | IsoRay Inc Fourth Quarter Earnings Conference Call in 2019 |
| 09/25/2019 | Earnings | IsoRay Inc Fourth Quarter Earnings in 2019 Release |
| 11/08/2018 16:30 EST | Misc | IsoRay Inc First Quarter Earnings Conference Call in 2019 |
| 11/08/2018 | Earnings | IsoRay Inc First Quarter Earnings in 2019 Release |
| 09/25/2018 16:30 EDT | Misc | IsoRay Inc Fourth Quarter Earnings Conference Call in 2018 |
| 09/25/2018 | Earnings | IsoRay Inc Fourth Quarter Earnings in 2018 Release |
ISR Fundamentals
Income Statement View Statement
ISR Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ISR One Page Reports
- One Page Report Download
ISR Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 0.3789 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.isoray.com
- Investor Relations URL: https://isoray.com/about/investors/
- HQ State/Province: Washington
- Sector: Healthcare
- Industry: Medical Instruments & Supplies
- Equity Style: Small Cap/Blend
- Next Earnings Release: Sep. 25, 2019
- Last Earnings Release: Nov. 08, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: IsoRay Inc offers is a medical technology company. The company designs and develops personalized brachytherapy products that provide a more cost-effective cancer treatment. It is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor. IsoRay derives most of its revenue from the United States of America.
ISR Excel Add-In Codes
- Name: =YCI("ISR","name")
- Description: =YCI("ISR","description")
- Sector: =YCI("ISR","sector")
- Industry: =YCI("ISR","industry")
- Est. Current Fiscal Year End: =YCI("ISR","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ISR Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ISR Tweets Stocktwits
Advertisement
